Retrasos en el diagnóstico y tratamiento del cáncer de mama en Medellín, Colombia / Delays in the diagnosis and treatment of breast cancer in Medellín, Colombia
Ginecol. obstet. Méx
;
90(12): 943-950, ene. 2022. tab
Article
in Spanish
|
LILACS-Express
| LILACS
| ID: biblio-1430424
RESUMEN
Resumen OBJETIVO:
Determinar los retrasos en el diagnóstico y tratamiento de pacientes con cáncer de mama atendidas en Medellín, Colombia, y describir sus características sociodemográficas y clínicas. MATERIALES YMÉTODOS:
Estudio retrospectivo, observacional y analítico de corte transversal efectuado en mujeres con cáncer de mama del registro personal de un cirujano. Se consideró retrasos en el paciente, proveedor y total, definidos como el tiempo trascurrido mayor a 90, 30 y 30 días, respectivamente; se recopilaron los datos demográficos, clínicos y paraclínicos. Para el análisis se utilizó estadística descriptiva.RESULTADOS:
Se estudiaron 331 mujeres de las que 98.6% contaba con aseguramiento en salud; el 80.1% (n= 265) tuvieron retraso total del tratamiento, el 76.1% (n = 270) tuvo demora del paciente y el 78% (n = 277) demora del proveedor. En el análisis bivariado se establecieron asociaciones significativas entre un retraso total y el pertenecer al régimen subsidiado (OR = 1.17; IC95% 1.06-1.29; p = 0.008).CONCLUSIÓN:
En la muestra estudiada se encontraron retrasos importantes debidos a la responsabilidad de la paciente y el proveedor, y un retraso total del tratamiento asociado de forma significativa con pertenecer al régimen subsidiado.ABSTRACT
Abstract OBJECTIVE:
To determine the existence of delays in the diagnosis and treatment of breast cancer in women treated in Medellin (Colombia), to explore the associated factors, and to describe sociodemographic and clinical characteristics. MATERIALS ANDMETHODS:
Retrospective, observational and analytical cross-sectional study of 331 women with breast cancer in Medellin (Colombia) in the personal record of a surgeon. Delays in the patient, provider and total were considered, defined as the time elapsed greater than 90 days, 30 days and 30 days, respectively; Demographic, clinical, and paraclinical data were collected and analyzed using descriptive statistics.RESULTS:
98.6% of the women had health insurance; 80.1% (n= 265) presented total treatment delay, 76.1% (N= 270) had patient delay, and 78% (n=277) provider delay; In the bivariate analysis, significant associations were established between total delay and belonging to the subsidized regimen (OR= 1.17; 95% CI 1.06-1.29; p= 0.008).CONCLUSION:
Among the patients studied, important delays were found due to the responsibility of the patient and the provider, and a total delay to treatment significantly associated with belonging to the subsidized regimen.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Diagnostic study
/
Observational study
/
Prevalence study
/
Risk factors
Country/Region as subject:
South America
/
Colombia
Language:
Spanish
Journal:
Ginecol. obstet. Méx
Journal subject:
Gynecology
/
Obstetrics
Year:
2022
Type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Universidad CES/CO
Similar
MEDLINE
...
LILACS
LIS